Page last updated: 2024-09-23

phleomycins

Description

Phleomycins: Water-soluble, copper-containing low molecular weight polypeptides obtained from the culture medium of Streptomyces verticillus. They are specific inhibitors of DNA synthesis in bacteria and have been found to act as antitumor agents. They have also been used against rust fungi of plants. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

phleomycin : A mixture of glycopeptide antibiotics originally isolated from the bacterium Streptomyces verticillus whose components all contain a thiazolinylthiazole moiety and can form complexes with redox-active metals such as Co, Cu, and Fe. (Bleomycins are very similar to phleomycins, but have a bithiazole moiety in place of the thiazolinylthiazole moiety). [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID72511
SCHEMBL ID5058616
MeSH IDM0016611

Synonyms (12)

Synonym
nsc 616586
nsc 61586
nsc-61586
phleomycin
phleomycins
SCHEMBL5058616
unii-bn3e7wjn9x
J-002368
1422270-80-1
BN3E7WJN9X ,
nsc-616586
gtpl10954

Research

Studies (159)

TimeframeStudies, This Drug (%)All Drugs %
pre-199054 (33.96)18.7374
1990's41 (25.79)18.2507
2000's37 (23.27)29.6817
2010's25 (15.72)24.3611
2020's2 (1.26)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (2.38%)6.00%
Case Studies1 (0.60%)4.05%
Observational0 (0.00%)0.25%
Other163 (97.02%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]